Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,087Revenue $M9.8Net Margin (%)-1,732.9Altman Z-Score3.7
Enterprise Value $M928EPS $-3.4Operating Margin %-1,747.8Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.0Pre-tax Margin (%)-1,732.9Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %-4.9Quick Ratio5.7Cash flow > EarningsY
Price/Sales2925-y EBITDA Growth Rate %28.7Current Ratio5.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-57.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-66.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M41.5ROIC % (ttm)-506.2Gross Margin Increase y-yN

Gurus Latest Trades with SRPT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SRPTGeorge Soros 2014-12-31 Sold Out -0.05%$12.6 - $23.56
($16.84)
$ 26.2256%Sold Out0
SRPTGeorge Soros 2014-09-30 Reduce-0.08%$19.9 - $30.27
($22.49)
$ 26.2217%Reduce 52.21%325,000
SRPTGeorge Soros 2014-06-30 Add0.14%$22.18 - $38.91
($31.64)
$ 26.22-17%Add 2620.00%680,000
SRPTGeorge Soros 2014-03-31 Reduce-0.04%$17.91 - $30.29
($25.36)
$ 26.223%Reduce 89.27%25,000
SRPTGeorge Soros 2013-12-31 Reduce-0.22%$12.89 - $53.81
($29.58)
$ 26.22-11%Reduce 64.98%233,000
SRPTGeorge Soros 2013-09-30 Add0.12%$30.906 - $47.97
($38.37)
$ 26.22-32%Add 56.28%665,274
SRPTGeorge Soros 2013-03-31 Add0.08%$23.97 - $36.95
($28.83)
$ 26.22-9%Add 82.54%413,329
SRPTGeorge Soros 2012-12-31 Add0.05%$14.99 - $44.93
($26.74)
$ 26.22-2%Add 184.13%226,429
SRPTFirst Eagle Investment 2012-03-31 Sold Out $4.44 - $9.6
($6.51)
$ 26.22303%Sold Out0
SRPTFirst Eagle Investment 2011-12-31 Reduce$3.24 - $6.54
($4.96)
$ 26.22429%Reduce 83.33%8,333
SRPTFirst Eagle Investment 2011-09-30 Add$6.3 - $9.9
($7.86)
$ 26.22234%Add 50.00%50,000
SRPTFirst Eagle Investment 2011-06-30 Buy $8.1 - $11.22
($9.69)
$ 26.22171%New holding33,333
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SRPT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SRPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Kaye Edward M. MDSVP & Chief Medical Officer 2015-02-27Buy800$11.82105.25 view
Christopher Nishan GarabedianPresident and CEO 2015-02-27Buy800$11.82105.25 view
CHASE ANTHONY RDirector 2013-11-14Buy10,000$13.9573.91 view
Aphale JayantSVP Technical Operations 2013-11-12Sell15,933$12.5693.15 view
BEHRENS M KATHLEENDirector 2013-09-16Buy6,500$37.04-34.5 view
HODGMAN JOHNDirector 2013-09-03Sell5,556$34.97-30.63 view
CHASE ANTHONY RDirector 2013-08-22Buy3,500$32.68-25.76 view
Mahatme SandeshSenior Vice President, CFO 2013-08-20Buy5,000$31.1-21.99 view
Price Ben GilDirector 2013-08-19Buy500$31.18-22.19 view
CHASE ANTHONY RDirector 2013-06-14Buy10,000$38.5-36.99 view

Press Releases about SRPT :

    Quarterly/Annual Reports about SRPT:

    News about SRPT:

    Articles On GuruFocus.com
    Sarepta Therapeutics Inc (SRPT) Will File NDA; Analysts Have Mixed Ratings May 20 2015 
    Wednesday’s Pre-Market Insights: Yahoo! Inc. (YHOO), Sarepta Therapeutics Inc (SRPT), Time Warner May 20 2015 
    Steven Cohen Keeps on Buying Biotechnological Companies May 04 2015 
    Ebola: Is The Cure Out There? Oct 14 2014 
    Insiders Are Buying Fate Therapeutics Oct 09 2013 
    comment on SRPT Mar 16 2013 
    comment on SRPT Mar 16 2013 
    comment on SRPT Feb 16 2013 

    More From Other Websites
    Biotech stock set to double May 21 2015
    Sarepta Therapeutics downgraded by BofA/Merrill May 21 2015
    Sarepta’s Feast May Not Satisfy May 20 2015
    Stock Pops & Drops: SRPT, PBY, TWTR & FEYE May 20 2015
    Analysts See More Upside For Sarepta Therapeutics May 20 2015
    6 stocks to watch May 20 2015
    BUZZ-Sarepta news lifts other muscular distrophy stocks May 20 2015
    Sarepta Explodes On Monster Volume Following Progress With FDA May 20 2015
    Sarepta: Is There Upside After 50% Gain? May 20 2015
    Sarepta to Finish Eteplirsen Regulatory Filing by Mid-15 - Analyst Blog May 20 2015
    Sarepta Soars On New Hope For Muscular-Dystrophy Drug May 20 2015
    Sarepta Therapeutics (SRPT) Stock Soars Following Positive Meeting With FDA May 20 2015
    How Sarepta Short Interest Is Adding to Its Gains May 20 2015
    Jim Cramer -- Regeneron Will Go Higher; Sarepta Is Rallying May 20 2015
    Cramer's Mad Dash: Regeneron goes higher May 20 2015
    Watch These After-Hours Movers May 20 2015
    Stock Futures Aim For Mixed Open; Sarepta Soars, Etsy Heads South May 20 2015
    Sarepta shares surge on muscular dystrophy drug filing May 19 2015
    After-hours buzz: Yahoo, Etsy & more May 19 2015
    Sarepta Shares Surge on Drug Update May 19 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK